Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Fish and Richardson
QuintilesIMS
Cantor Fitzgerald
US Department of Justice
Medtronic
Daiichi Sankyo
Federal Trade Commission

Generated: February 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,622,985

« Back to Dashboard

Summary for Patent: 5,622,985
Title: Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
Abstract:A method is provided for preventing or reducing the risk of a second heart attack in a patient having a substantially normal serum cholesterol level by administering an HMG CoA reductase inhibitor such as pravastatin, alone or in combination with an ACE inhibitor.
Inventor(s): Olukotun; Adeove Y. (Hopewell, NJ), Alexander; John C. (Winnetka, IL)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:08/424,984
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,622,985
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,622,985

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
Fish and Richardson
Chubb
Accenture
McKesson
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.